Cargando…

Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review

BACKGROUND: Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control with drugs may reduce long-term CVD risk. Bromocriptine has been in clinical use for over 30 years, but the utility of brom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birhan, Mulualem Tesfaye, Ayele, Teklie Mengie, Abebe, Fikire Wondimu, Dgnew, Fiseha Nigussie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324265/ https://www.ncbi.nlm.nih.gov/pubmed/37415177 http://dx.doi.org/10.1186/s13098-023-01073-2

Ejemplares similares

A Comparative Study of Hematological Parameters of Endurance Runners at Guna Athletics Sport Club (3100 Meters above Sea Level) and Ethiopian Youth Sport Academy (2400 Meters above Sea Level), Ethiopia
por: Tilahun Muche, Zelalem, et al.
Publicado: (2021)

Investigation of Antibacterial and Anti-Diarrhoeal Activities of 80% Methanol Leaf and Fruit Extract of Leonotis ocymifolia (Burm. F) Iwarsson (Lamiaceae)
por: Mengie Ayele, Teklie, et al.
Publicado: (2021)

Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients
por: Khalilzade, Saied Hossein, et al.
Publicado: (2015)

Evaluation of Wound Healing and Antibacterial Activities of Solvent Fractions of 80% Methanol Leaf Extract of Brucea antidysenterica J.F. Mill (Simaroubaceae)
por: Wolde, Befekadu, et al.
Publicado: (2022)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

Phytochemical Investigation and Determination of Antibacterial Activity of Solvent Leave Extracts of Carissa spinarum
por: Ayalew Tiruneh, Tizezew, et al.
Publicado: (2022)

Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2021)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Publicado: (2015)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Via, Michael A, et al.
Publicado: (2010)

Evaluation of antibiotic utilization pattern in the treatment of acute diarrheal diseases at Debre Tabor comprehensive specialized hospital, Debre Tabor, Ethiopia: A retrospective cross-sectional study
por: Addis, Getu Tesfaw, et al.
Publicado: (2023)

Investigation of Wound Healing and Anti-Inflammatory Activities of Solvent Fractions of 80% Methanol Leaf Extract of Achyranthes aspera L. (Amaranthaceae) in Rats
por: Mengie, Teklie, et al.
Publicado: (2021)

Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review
por: Mengie Ayele, Teklie, et al.
Publicado: (2022)

Assessment of Dispensing Malpractice in Community Drug Retail Outlets in South Gondar Zone, Northwest Ethiopia: A Simulated Patient Experience
por: Bogale Kassie, Achenef, et al.
Publicado: (2023)

Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study
por: Nigussie, Shambel, et al.
Publicado: (2021)

Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes
por: Ramteke, Karuna Balwant, et al.
Publicado: (2011)

Investigation of Wound Healing and Anti-Inflammatory Activities of Leaf Gel of Aloe trigonantha L.C. Leach in Rats
por: Tazeze, Haile, et al.
Publicado: (2021)

Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
por: Tekalegn, Yohannes, et al.
Publicado: (2018)

The Role of Regulatory B Cells in Health and Diseases: A Systemic Review
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2021)

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
por: Mahajan, Rajiv
Publicado: (2009)

Cardiovascular and Renal Effects of Bromocriptine in Diabetic Patients with Stage 4 Chronic Kidney Disease
por: Mejía-Rodríguez, Oliva, et al.
Publicado: (2013)

Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
por: Gaziano, J. Michael, et al.
Publicado: (2010)

Relevance of the Glycemic Index and Glycemic Load for Body Weight, Diabetes, and Cardiovascular Disease
por: Vega-López, Sonia, et al.
Publicado: (2018)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Role of Fetuin-A in the Pathogenesis of Psoriasis and Its Potential Clinical Applications
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

Prediction of response to bromocriptine in acromegaly.
por: Atkinson, A. B., et al.
Publicado: (1978)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017)

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control
por: Keche, Yogendra
Publicado: (2010)

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
por: Chamarthi, Bindu, et al.
Publicado: (2015)

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
por: DeFronzo, Ralph A.
Publicado: (2011)

Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes
por: Oshige, Tamami, et al.
Publicado: (2019)

Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats
por: Nade, Vandana S., et al.
Publicado: (2012)

Bromocriptine, a clinical and pharmacological review /
por: Thorner, Michael O.
Publicado: (1980)

The structure, biosynthesis, and biological roles of fetuin-A: A review
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

Levels and Determinants of Prenatal Breastfeeding Knowledge, Attitude, and Intention Among Pregnant Women: A Cross-Sectional Study in Northwest Ethiopia
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

Determinants of delay in care seeking for diarrheal diseases among mothers/caregivers with under-five children in public health facilities of Arba Minch town, southern Ethiopia; 2019
por: Fikire, Alemayehu, et al.
Publicado: (2020)

Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

Level of knowledge, attitude, and practice on modern contraceptive method and its associated factors among housemaids living in Debre Tabor town, northwest Ethiopia: a community-based cross-sectional study
por: Tiruneh, Gebrehiwot Ayalew, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l4sf8m5bvfm92ch1k72s8qm561